| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $93.7M | -17.0% |
| SG&A Expense | $43.4M | +12.7% |
| Operating Income | -$137.1M | +9.4% |
| Income Tax | $0 | — |
| Net Income | -$133.2M | +11.8% |
| EPS (Basic) | -$2.37 | +14.1% |
| EPS (Diluted) | -$2.37 | +14.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $76.0M | -61.7% |
| Short-term Investments | $162.2M | +14.8% |
| Current Assets | $244.3M | -29.7% |
| Total Assets | $294.9M | -24.7% |
| Current Liabilities | $21.5M | +57.7% |
| Total Liabilities | $50.4M | +8.8% |
| Stockholders' Equity | $244.5M | -29.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$90.9M | +22.9% |
| Capital Expenditures | $577K | -86.5% |
| Investing Cash Flow | -$32.2M | -150.6% |
| Financing Cash Flow | $851K | -80.9% |
| Free Cash Flow | -$91.5M | +25.1% |